Clinical Trials Logo

Clinical Trial Summary

Gestational diabetes (GDM) means raised blood glucose found for the first time in pregnancy. GDM is common, particularly in women from minority ethnicities. GDM does not cause any symptoms in the mother. GDM is associated with adverse pregnancy outcomes which can be improved with treatment of GDM. The United Kingdom National Institute for Health and Care Excellence (NICE) recommend pregnant women with one or more risk factors should have a 75g oral glucose tolerance test (OGTT). The OGTT is performed in a clinic with venous plasma glucose measured fasting and at 2 hours. This is resource-intensive, and some women with GDM may be missed by this risk-factor based approach. The International Association of Diabetes and Pregnancy Study Groups (IADPSG 2010) recommends screening all pregnant women with 2-hour, 3 sample (fasting, 1 and 2 hour), 75g OGTT, which is even more resource intensive. Developing more cost-effective and convenient approaches to screening for GDM is a priority.

The researchers will validate a new home-use OGTT system (hOGTT), which measures whole blood glucose in capillary blood ('finger-stick' sample), against the gold standard venous plasma glucose in pregnancy.

The researchers will also investigate the performance of glycated haemoglobin (HbA1c) in screening for GDM. HbA1c is used for diagnosis of diabetes outside of pregnancy, but is currently not recommended for screening for GDM.

The researchers will also investigate relationships between glucose measured in different samples (venous versus capillary), different fractions (plasma versus whole blood), and using different methods in pregnancy.

In a substudy the researchers will investigate: ethnic differences in HbA1c and other glycaemic markers; the contribution of fasting and postprandial glucose handling, diet and ethnicity on HbA1c; and ethnic differences in insulin responses to 75g OGTT in pregnancy.

The researchers will invite pregnant women between 16-34 weeks gestation to participate. The research involves one hospital visit for an OGTT. Participants will have venous blood samples taken fasting and at 1-hour and 2-hours, and at the same times finger-stick blood samples will be tested. The researchers will invite women of Black African, Black Caribbean and White European ethnicity to participate in a substudy in which participants will have extra blood taken and a diet assessment.

If the hOGTT provides accurate results in pregnancy, using it to perform OGTTs at home would make screening for GDM less expensive and more convenient and may facilitate universal screening for GDM. Understanding ethnic differences in HbA1c will help determine if HbA1c is a reliable screening tool for GDM in our ethnically diverse local population.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03117543
Study type Observational
Source King's College Hospital NHS Trust
Contact Katharine F Hunt, MBBS MRCP
Phone 00442078485663
Email katharine.f.hunt@kcl.ac.uk
Status Recruiting
Phase
Start date March 2016

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Completed NCT01940003 - Effects of an Aquatic Physical Exercise Program on Glycaemic Control and Perinatal Outcomes of Gestational Diabetes: Study Protocol for a Randomized Controlled Trial N/A
Completed NCT02960295 - The Virtual Visit for Women With Gestational Diabetes N/A
Completed NCT01919476 - Postprandial Response to Almond Consumption in Overweight Hispanic Pregnant Women N/A
Completed NCT05512871 - A Mobile Health-enabled Lifestyle Intervention Among Women With History of Gestational Diabetes(GDM) N/A
Enrolling by invitation NCT03307486 - Gestational Diabetes: a Cohort Study N/A
Active, not recruiting NCT04417452 - Long-term Outcome After Gestational Diabetes and Diabetes in Pregnancy
Completed NCT02968628 - Effect of Maternal Diabetes on Brain Development, as Measured by Neonatal Electroencephalogram (EEG)
Active, not recruiting NCT04222348 - MeDiGes Study: Metformine Use in Gestational Diabetes Phase 3
Completed NCT03007186 - Glucose Monitoring During Threatening Preterm Birth in Patients With and Without Gestational Diabetes Mellitus
Completed NCT00069576 - Gestational Diabetes Mellitus Trial (GDM) N/A
Completed NCT04866823 - Meals for Moms: Medically-Tailored Meals for Women Who Had Gestational Diabetes N/A
Recruiting NCT04198857 - Development and Testing of a Mobile Health Application for Management of Gestational Diabetes N/A
Recruiting NCT05115188 - DIAgnosing GDM usiNg Oral Sugar InStead Phase 2
Recruiting NCT03607799 - A Culturally-tailored Personalized Nutrition Intervention in South Asian Women at Risk of Gestational Diabetes N/A
Recruiting NCT02893072 - Medical Nutrition Therapy Intervention Program for Women With Gestational Diabetes--a Prospective Study N/A
Enrolling by invitation NCT05368220 - Translating Genetic Knowledge Into Clinical Care in Non-Autoimmune Diabetes
Completed NCT02770079 - Insulin Sensitivity and Secretion During Pregnancy and Post Partum in Women With Gestational Diabetes.
Completed NCT00681460 - Metformin in Gestational Diabetes Mellitus N/A
Completed NCT02931656 - Acute Effects of an Aquatic Physical Exercise on Glycemic Control of Gestational Diabetes N/A